Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Quantum Simulation Technologies is raising $5,830,794.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Toru Shiozaki played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Quantum Simulation Technologies

We are looking to bring the power of quantitative simulations to solve pressing problems in the pharmaceutical and chemistry spaces. Our unique technology allows the customers to scale their quantum mechanical simulations to thousands of molecules per day and achieve high throughput. Our platform automates the workflow and takes advantage of low-cost options available in the cloud, such as AWS’s spot pricing. The application scope ranges from creating an AI model in Materials Informatics to screening small molecules in drug discovery processes. Our offices are located in Cambridge MA and Pasadena CA, USA, and Ghent, Belgium.

To learn more about Quantum Simulation Technologies, visit http://qsimulate.com/

Contact:
Toru Shiozaki, President and Chief Executive Officer
847-626-5535
shiozaki@qsimulate.com
https://www.linkedin.com/in/toru-shiozaki-7368338a/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved